These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30974480)

  • 1. Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma.
    Matsuno R; Toyama D; Akiyama K; Isoyama K; Shiozawa E; Yamamoto S
    Pediatr Int; 2019 Jun; 61(6):566-571. PubMed ID: 30974480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
    Fukuda M; Miyajima Y; Miyashita Y; Horibe K
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma: treatment outcome after incomplete resection of primary tumors.
    Moon SB; Park KW; Jung SE; Youn WJ
    Pediatr Surg Int; 2009 Sep; 25(9):789-93. PubMed ID: 19629500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of high-dose
    Lee JW; Kang ES; Sung KW; Yi E; Lee SH; Yoo KH; Koo HH
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 28012219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous cord blood transplantation in a child with stage 4 neuroblastoma.
    Wu KH; Wang SM; Wu HP; Weng T; Peng CT; Chao YH
    Bone Marrow Transplant; 2013 Feb; 48(2):317-8. PubMed ID: 22858506
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
    Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
    Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk neuroblastoma patients.
    Molina B; Alonso L; Gonzalez-Vicent M; Andion M; Hernandez C; Lassaletta A; Cormenzana M; Lopez-Ibor B; Villa M; Molina J; Diaz MA
    Pediatr Hematol Oncol; 2011 Mar; 28(2):115-23. PubMed ID: 21299340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
    Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid].
    Tang SQ; Huang DS; Wang JW; Zhang XF; Liu LZ; Yu F; Yang G
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):486-9. PubMed ID: 15324562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN.
    Goi K; Inukai T; Honna H; Akahane K; Hirose K; Kuroda I; Hasuda N; Koshizuka K; Takano K; Sugita K
    Bone Marrow Transplant; 2011 Jun; 46(6):835-9. PubMed ID: 20697365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The strategy to treat disseminated neuroblastoma utilizing bone marrow transplantation: what is the surgeon's role?
    Yokoyama S; Hirakawa H; Soeda J; Ueno S; Tajima T; Mitomi T; Yabe H; Yabe M; Kato S
    Surg Today; 1994; 24(10):895-9. PubMed ID: 7894187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
    Kaneko M; Tsuchida Y; Mugishima H; Ohnuma N; Yamamoto K; Kawa K; Iwafuchi M; Sawada T; Suita S
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):613-21. PubMed ID: 12439032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive treatment of advanced neuroblastoma involving autologous bone marrow transplant.
    Mugishima H; Harada K; Suzuki T; Chin M; Shimada T; Takamura M; Shichino H; Fujisawa T; Ichikawa M; Iwata M
    Acta Paediatr Jpn; 1995 Aug; 37(4):493-9. PubMed ID: 7572151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
    Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of surgical resection in children with high-risk neuroblastoma.
    Englum BR; Rialon KL; Speicher PJ; Gulack B; Driscoll TA; Kreissman SG; Rice HE
    Pediatr Blood Cancer; 2015 Sep; 62(9):1529-35. PubMed ID: 25810376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
    Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Tushabe DA; Berthold F
    Cochrane Database Syst Rev; 2015 Jan; 1():CD010685. PubMed ID: 25634649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: pilot study.
    Pardo N; Martí F; Fraga G; Illa J; Badell I; Peiró M; Bertran E; García J; Rueda F; Cubells J
    Med Pediatr Oncol; 1996 Dec; 27(6):534-9. PubMed ID: 8888813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma.
    Illhardt T; Toporski J; Feuchtinger T; Turkiewicz D; Teltschik HM; Ebinger M; Schwarze CP; Holzer U; Lode HN; Albert MH; Gruhn B; Urban C; Dykes JH; Teuffel O; Schumm M; Handgretinger R; Lang P
    Biol Blood Marrow Transplant; 2018 May; 24(5):1005-1012. PubMed ID: 29307718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.